| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |